3 news items
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
RYTM
22 May 24
collaborations, or the failure of these collaborations, our reliance on third parties, risks relating to intellectual property, our ability to hire
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
RYTM
16 Apr 24
anniversary of the applicable date of hire of each individual, with the remaining 75% vesting in 12 equal quarterly installments over the three years
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
RYTM
11 Mar 24
anniversary of the applicable date of hire of each individual, with the remaining 75% vesting in 12 equal quarterly installments over the three years
- Prev
- 1
- Next